NTRK1 and melanoma: KIT encodes a receptor tyrosine kinase protein named mast/stem cell growth factor receptor (SCFR), which stimulates both the MAPK and PI3K-Akt pathways; thus, in melanoma, mutations in KIT lead to deregulated growth and survival of cells [42].